Description
A 13-methyl-substituted derivative of berberine; has antibacterial, anti-inflammatory, anti-obesity, and hypercholesterolemic activity; has improved antibacterial activity against S. aureus (MIC = 125 µg/ml) and improved antitumor activity compared to berberine; induces down-regulation of adipocyte differentiation transcription factors; reduces de novo lipid synthesis
Formal name: 5,6-dihydro-9,10-dimethoxy-13-methyl-benzo[g]-1,3-benzodioxolo[5,6-a]quinolizinium, monochloride
Synonyms: 13-MB
Molecular weight: 385.8
CAS: 54260-72-9
Purity: ≥98%
Formulation: A crystalline solid
Product Type|Biochemicals|Antibiotics||Product Type|Biochemicals|Natural Products|Alkaloids||Research Area|Cancer||Research Area|Endocrinology & Metabolism||Research Area|Immunology & Inflammation||Research Area|Infectious Disease|Bacterial Diseases